AVDL
NASDAQ · Pharmaceuticals
Avadel Pharmaceuticals
$21.64
+0.01 (+0.05%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+0.05%
1Y
+69.19%
YTD
+0.56%
Open$21.66
Previous Close$21.63
Day High$21.76
Day Low$21.63
52W High$23.57
52W Low$10.79
Volume—
Avg Volume4.77M
Market Cap2.12B
P/E Ratio—
EPS$-0.01
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$21.51
Above
SMA 200
$15.56
Above
RSI (14)
61.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
16 analysts
Price Target
+437.3% upside
Current
$21.64
$21.64
Target
$116.27
$116.27
$84.09
$116.27 avg
$133.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 174.47M | 88.85M | 342.21M |
| Net Income | -50,382,173 | -23,091,080 | 102.70M |
| Profit Margin | -28.9% | -27.4% | 30.0% |
| EBITDA | -40,979,071 | -19,824,880 | 141.15M |
| Free Cash Flow | — | — | 87.98M |
| Rev Growth | +96.4% | +96.4% | -4.7% |
| Debt/Equity | 0.48 | 0.48 | 0.61 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |